Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe? - Wikidata - awgldk - TriplyDB

Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?

Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?

http://www.wikidata.org/entity/Q38059198

about

Cardiorenal syndrome: a cardiologist's perspective of pathophysiology Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension Update in pulmonary vascular diseases 2013.NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.Pulmonary hypertension and the right ventricle-thinking outside the box (Third International Right Heart Failure Summit, part 1).Protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension Interventricular differences in β-adrenergic responses in the canine heart: role of phosphodiesterases.The need to recognize the pulmonary circulation and the right ventricle as an integrated functional unit: facts and hypotheses (2013 Grover Conference series).Current clinical management of pulmonary arterial hypertension Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma.Circulating Aldosterone Levels and Disease Severity in Pulmonary Arterial Hypertension.Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension: Relative Contribution of Fibrosis and Myofibril Stiffness.Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension.Right heart imaging in patients with heart failure: a tale of two ventricles.Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension.Prognostic value of mean pulmonary artery pressure in the stable phase after heart transplantation.Treatment strategies for the right heart in pulmonary hypertension.RV pressure overload: from hypertrophy to failure.Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome.Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis Inflammation in Right Ventricular Failure: Does It Matter?Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting

P2860

Q27023089-1851861F-3DBA-423B-8495-3244C0F27933 Q28085007-180B80CD-C379-46DF-902D-A34F94A2D51A Q33732209-EA4A4F32-8430-4FC6-BBBB-216376B47937 Q34025109-2ED1D21D-7F5B-462C-8F0A-0B9D45555A4C Q34782622-BF92DD03-5B2D-4A29-89C9-8F0267BFEDC2 Q35021804-243BEC3F-F3F4-49CB-A2A2-63703116CDBD Q35021924-56A30328-DD1E-4C1A-9510-BACDB7032174 Q35517479-33308D3F-7C6D-41E9-A137-6540C1E91CD1 Q35673783-8992C104-614C-4CA4-922B-D687FE52CE0A Q36468672-4161E4DB-2A4B-46EF-8C25-D2B268E5949F Q36883558-14306C49-0742-4472-AC05-F29C40E5B324 Q37116376-EE321E2A-405C-4130-B0B2-C61663663362 Q38271119-F6652F88-7C62-4C0A-916C-DC530E1DFD33 Q38911015-754B041E-2F08-4B4A-974A-A40B9A790E76 Q42370379-70CA5518-2D38-41EC-AEF5-54BAF97D3FFE Q47348661-9368F221-D59E-4321-BFFF-31F91D6CEA0A Q47622646-8B6C4109-6DED-4C78-A3E4-CD0091D81832 Q49679389-2F2CABBE-E80C-4ADD-A57E-ABFF72144A75 Q55512217-16E9D8BA-882C-4697-9D2A-63BA2AAEF100 Q57823948-4D79DF20-04C7-4119-AB1A-21F747D4AF83 Q58735426-011327BB-765A-4BD5-99D7-C266262AC694 Q58804808-11284686-99BF-480D-BFA7-7714CC0821C3

P2860

Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?

http://www.wikidata.org/entity/Q38059198

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?

@en

type

label

Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?

@en

prefLabel

Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?

@en

P1433

Q38059198-DB4075A9-37D7-4B90-9778-A8E5DE5B6373

P1476

Q38059198-EAE876B6-C80E-45F3-9CA4-877BEE872B73

P2093

Q38059198-0A22D16C-A41A-4632-855C-02B070C53AA6

Q38059198-89F145FF-5FBF-4E62-A1A6-1E871B5E00C1

Q38059198-FCAB7C33-532E-4966-B0FA-A7A7CFC23441

P2860

Q38059198-003FFA15-0064-4B46-81FF-6BCDDCD90BE3

Q38059198-1CB562CF-7458-4708-A630-725FF42FDC91

Q38059198-2102AD19-8072-4083-AA51-A89C7F76D047

Q38059198-2107BB34-1CA8-42C6-A228-DFE28FB90065

Q38059198-261A431E-8E79-4843-B997-CFD53B7F7157

Q38059198-2D610931-3401-4D9C-8FD1-C68ECDB4D2FA

Q38059198-3097EC19-C0E4-433C-9C55-4D96E2DC9628

Q38059198-36E7AEA8-1ECB-4C0B-A095-062A513D4F4F

Q38059198-38A9324D-BD7A-40DD-88D3-4AC0442184C5

Q38059198-3A4C8BE2-C18A-4C49-85A5-31E1CAF66575

P304

Q38059198-1B6CC366-DBC8-4CCC-B858-A6CB3968E175

P31

Q38059198-E3B39CEA-B1AB-4958-8D15-4DE07277DA6B

P356

Q38059198-C0F25942-2E47-4896-A448-A3163A68B9B9

P407

Q38059198-8B3AFF1F-7D81-4D7C-8BC5-7323E0BA7CEC

P433

Q38059198-E57A65C6-2771-4715-8210-9792182572BC

P478

Q38059198-863EE1C7-E085-4893-8C7C-97589E8C9577

P50

Q38059198-0A311272-D74C-429E-873C-CA42F752868B

Q38059198-3FC5CE6F-299A-40DA-9F76-F5FDAFB4395F

P577

Q38059198-181FBEFA-352B-44E7-AADF-B7AFDE894D44

P698

Q38059198-1E30CC98-17CF-4410-B7FB-A16D4EF4D00F

P921

Q38059198-8F772F1B-6C11-466B-933C-E61B8DF385A8

P356

RCCM.201209-1663PP

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?

@en

P2093

Anton Vonk-Noordegraaf

http://www.w3.org/2001/XMLSchema#string

Frances S de Man

http://www.w3.org/2001/XMLSchema#string

Harm J Bogaard

http://www.w3.org/2001/XMLSchema#string

P2860

Über humorale Übertragbarkeit der Herznervenwirkung

Safety and efficacy of exercise training in various forms of pulmonary hypertension.

Interactions between endothelin-1 and the renin-angiotensin-aldosterone system.

ACE2 improves right ventricular function in a pressure overload model.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.

Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension.

Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension.

Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system.

Polymorphism in the angiotensin II type 1 receptor (AGTR1) is associated with age at diagnosis in pulmonary arterial hypertension

P304

14-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201209-1663PP

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

187

http://www.w3.org/2001/XMLSchema#string

P50

Christophe Guignabert

M Louis Handoko

P577

2012-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23144327

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension